Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 1998
Does the human immunodeficiency virus (HIV) RNA concentration in cerebrospinal fluid help clinicians diagnose or understand HIV-induced neurological disease?
E S Daar
Positive Living (Los Angeles, Calif.)
|
September 11, 2001
Putting resistance to the test
E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 30, 1998
Potent antiretroviral therapy does more than just decrease viral load
E S Daar
AIDS Research and Human Retroviruses
|
November 14, 1998
Virology and immunology of acute HIV type 1 infection
E S Daar
The Journal of Infectious Diseases
|
January 1, 1993
Infectious decay of human immunodeficiency virus type 1 in plasma
T Moudgil, E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 7, 1998
Utility of fungal blood cultures for patients with AIDS
T Mess, E S Daar
Postgraduate Medicine
|
April 25, 2000
Primary HIV infection. Current trends in transmission, testing, and treatment
K Yu, E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 1999
Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations
P Gaut, E S Daar
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Dual protease inhibitor therapy in the management of the HIV-1
K Yu, E S Daar
The American Journal of Medicine
|
April 10, 1991
Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4
E S Daar, D D Ho
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 1998
Does the human immunodeficiency virus (HIV) RNA concentration in cerebrospinal fluid help clinicians diagnose or understand HIV-induced neurological disease?
E S Daar
Positive Living (Los Angeles, Calif.)
|
September 11, 2001
Putting resistance to the test
E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 30, 1998
Potent antiretroviral therapy does more than just decrease viral load
E S Daar
AIDS Research and Human Retroviruses
|
November 14, 1998
Virology and immunology of acute HIV type 1 infection
E S Daar
The Journal of Infectious Diseases
|
January 1, 1993
Infectious decay of human immunodeficiency virus type 1 in plasma
T Moudgil, E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 7, 1998
Utility of fungal blood cultures for patients with AIDS
T Mess, E S Daar
Postgraduate Medicine
|
April 25, 2000
Primary HIV infection. Current trends in transmission, testing, and treatment
K Yu, E S Daar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 1999
Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations
P Gaut, E S Daar
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Dual protease inhibitor therapy in the management of the HIV-1
K Yu, E S Daar
The American Journal of Medicine
|
April 10, 1991
Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4
E S Daar, D D Ho
Page
of 6